Round Type
Series B
LexingtonBiotechnologyMedical Equipment ManufacturingDescription
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced the successful first close of its Series B fundraising round. Taken together with the exercise of outstanding warrants, this close brings an additional $18 million of equity capital from noted global private investors with deep finance and healthcare expertise. To date, the company has raised approximately $130mm (inclusive of $8mm in grant funding from the National Institutes of Health).
Quick answer
Hemanext raised an undisclosed amount in a Series B round, dated November 7, 2022. Hemanext is based in Lexington, Nebraska, United States.
- How much did Hemanext raise?
- Hemanext raised an undisclosed amount in a Series B round on November 7, 2022.
- What does Hemanext do?
- Hemanext is a medical technology company with headquarters and R&D Center of Excellence in Lexington MA, and manufacturing operations in Avon MA.
- Where is Hemanext based and how big is it?
- Hemanext is based in Lexington, Nebraska, United States.
- Who are the decision-makers at Hemanext?
- Fundz holds 1 contact at Hemanext. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical Equipment Manufacturing and Biotechnology around the same time
Companies in the same sectors as Hemanext that raised within 45 days of this round, from Fundz verified event records.
- Synchron raised $75M (Series C) on December 15, 2022.
- Synchron raised $72M on November 7, 2022.
- Iaso Therapeutics raised $438K (Seed) on December 22, 2022.
- Aspen Neuroscience raised $40M (Debt Financing) on December 22, 2022.
- Xeno Biosciences raised $1.5M (Seed) on December 22, 2022.
- Astek Diagnostics raised $350K (Seed) on December 22, 2022.
Who to call at Hemanext, and when
A new round usually means Hemanext is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Hemanext raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Hemanext, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Hemanext. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Hemanext raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansHemanext raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.